PDF herunterladen
Am J Perinatol 2019; 36(11): 1127-1135
DOI: 10.1055/s-0038-1676489
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Associations between Maternal Exposure to Bisphenol A or Triclosan and Gestational Hypertension and Preeclampsia: The MIREC Study

Louopou Rosalie Camara
1   Social and Preventive Medicine Department, Public Health School, Université de Montréal, Quebec, Canada
2   Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada
,
Tye Elaine Arbuckle
3   Population Studies Division, Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Ontario, Canada
,
Helen Trottier
1   Social and Preventive Medicine Department, Public Health School, Université de Montréal, Quebec, Canada
2   Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada
,
William Donald Fraser
2   Research Center, CHU Sainte-Justine, Mother and Child University Hospital Center, Montreal, Quebec, Canada
4   CHU Sherbrooke Research Center, Department of Obstetrics and Gynecology, Université de Sherbrooke, Sherbrooke, Quebec, Canada
› Institutsangaben Funding The MIREC Study was funded by Health Canada's Chemicals Management Plan, the Canadian Institute of Health Research (CIHR; grant MOP-81285), and the Ontario Ministry of the Environment. Author L.R.C. received a PhD scholarship from MIREC and QTNPR (Quebec Perinatal Research Training Network). Author H.T. holds a salary award (chercheur-boursier) from the Fonds de la recherche du Québec en santé (FRQ-S) and from CIHR (New investigator salary award). Author W.D.F. holds a Tier 1 CIHR Canada Research Chair.
Weitere Informationen

Publikationsverlauf

22. Juni 2018

25. Oktober 2018

Publikationsdatum:
14. Dezember 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Background Little is known about the association between bisphenol A (BPA) or triclosan (TCS) exposure and hypertension in pregnancy.

Objective To investigate potential associations between maternal urinary concentrations of BPA or TCS and gestational hypertension (GH) and preeclampsia.

Study Design Among 1,909 pregnant women participating in the maternal-infant research on environmental chemicals (MIREC) study, urinary concentrations of BPA and TCS were measured in the first trimester by liquid chromatography-tandem mass spectrometry using isotope dilution. Blood pressure was measured during each trimester. Multinomial regression was performed to estimate the adjusted odds ratio (aOR) and 95% confidence intervals (CI) for the associations between these phenols and GH and preeclampsia.

Results BPA and TCS were not associated with GH or preeclampsia. However, in multiparous women, BPA (0.50–1.30 µg/L) was associated with decreased risk of GH (aOR =0.45; 95%CI: 0.21–0.98) while among nulliparous women, TCS was associated with an increased risk of GH (3.60–32.60 µg/L; aOR = 2.58; 95% CI: 1.09–6.13 and > 32.60 µg/L: aOR = 2.74; 95% CI: 1.15–6.51).

Conclusion BPA and TCS urinary concentrations were not associated with GH or preeclampsia; however, our results suggest an association between TCS and GH in nulliparous women. Additional studies are required to confirm our results.

Keywords

BPA - TCS - gestational hypertension - preeclampsia - pregnancy - pregnant woman - phenols - environmental chemicals

Supplementary Material

 

  • References

  • 1 Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53 (06) 944-951
    CrossrefPubMedSuche in Google Scholar
  • 2 Nakimuli A, Nakubulwa S, Kakaire O. , et al. The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: a prospective cohort study from Uganda. BMC Pregnancy Childbirth 2016; 16: 205
    CrossrefPubMedSuche in Google Scholar
  • 3 Riaz S, Habib S, Jabeen A. Frequency of maternal mortality and morbidity in pregnancy-induced hypertension. J Ayub Med Coll Abbottabad 2011; 23 (04) 61-63
    PubMedSuche in Google Scholar
  • 4 Berhan Y, Endeshaw G. Maternal mortality predictors in women with hypertensive disorders of pregnancy: a retrospective cohort study. Ethiop J Health Sci 2015; 25 (01) 89-98
    CrossrefPubMedSuche in Google Scholar
  • 5 Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 2013; 25 (02) 124-132
    CrossrefPubMedSuche in Google Scholar
  • 6 Moodley J. Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study. Hypertens Pregnancy 2004; 23 (03) 247-256
    CrossrefPubMedSuche in Google Scholar
  • 7 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (03) 130-137
    CrossrefPubMedSuche in Google Scholar
  • 8 Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. ; Canadian Hypertensive Disorders of Pregnancy Working Group Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36 (05) 416-441
    CrossrefPubMedSuche in Google Scholar
  • 9 Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21 (05) 521-526
    CrossrefPubMedSuche in Google Scholar
  • 10 Public Health Agency of Canada. Maternal hypertension in Canada. October 2014. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/maternal-hypertension-canada.html . Accessed August 16, 2017
    PubMed
  • 11 Ali SM, Khalil RA. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets 2015; 19 (11) 1495-1515
    CrossrefPubMedSuche in Google Scholar
  • 12 Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123 (24) 2856-2869
    CrossrefPubMedSuche in Google Scholar
  • 13 Robillard PY, Dekker G, Chaouat G. Sixth international workshop on reproductive immunology, immunological tolerance and immunology of preeclampsia. Preface. J Reprod Immunol 2009; 82 (02) 95
    CrossrefPubMedSuche in Google Scholar
  • 14 Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. J Reprod Immunol 2011; 89 (02) 104-117
    CrossrefPubMedSuche in Google Scholar
  • 15 Cantonwine DE, Meeker JD, Ferguson KK, Mukherjee B, Hauser R, McElrath TF. Urinary concentrations of bisphenol A and phthalate metabolites measured during pregnancy and risk of preeclampsia. Environ Health Perspect 2016; 124 (10) 1651-1655
    CrossrefPubMedSuche in Google Scholar
  • 16 Pregnancy hypertension. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, eds. Williams Obstetrics. 23rd edition. New York, NY. McGraw-Hill; 2010:706–756
  • 17 Kobashi G. Genetic and environmental factors associated with the development of hypertension in pregnancy. J Epidemiol 2006; 16 (01) 1-8
    CrossrefPubMedSuche in Google Scholar
  • 18 FDA (U.S. Food and Drug Administration). 5 things to know about triclosan. 2016a. Available at: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm205999.htm . Accessed July 14, 2017
    PubMed
  • 19 FDA (U.S. Food and Drug Administration). Bisphenol A (BPA): use in food contact application. 2016b. Available at: https://www.fda.gov/newsevents/publichealthfocus/ucm064437.htm . Accessed July 14, 2017
    PubMed
  • 20 GOC (Government of Canada). Triclosan. 2016. Available at: https://www.canada.ca/en/health-canada/services/chemicals-product-safety/triclosan.html . Accessed July 14, 2017
    PubMed
  • 21 GOC (Government of Canada). Bisphenol A in batch 2 of the challenge. 2017. Available at: https://www.canada.ca/en/health-canada/services/chemical-substances/challenge/batch-2/bisphenol-a.html . Accessed July 14, 2017
    PubMed
  • 22 Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 2002; 15 (10) 1281-1287
    CrossrefPubMedSuche in Google Scholar
  • 23 Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology 2006; 226 (2, 3): 79-89
    CrossrefPubMedSuche in Google Scholar
  • 24 Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24 (02) 139-177
    CrossrefPubMedSuche in Google Scholar
  • 25 von Goetz N, Pirow R, Hart A. , et al. Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A. Regul Toxicol Pharmacol 2017; 85: 70-78
    CrossrefPubMedSuche in Google Scholar
  • 26 Bae S, Hong YC. Exposure to bisphenol A from drinking canned beverages increases blood pressure: randomized crossover trial. Hypertension 2015; 65 (02) 313-319
    CrossrefPubMedSuche in Google Scholar
  • 27 Shiue I. Higher urinary heavy metal, arsenic, and phthalate concentrations in people with high blood pressure: US NHANES, 2009-2010. Blood Press 2014; 23 (06) 363-369
    CrossrefPubMedSuche in Google Scholar
  • 28 Wang T, Xu M, Xu Y. , et al. Association of bisphenol A exposure with hypertension and early macrovascular diseases in Chinese adults: a cross-sectional study. Medicine (Baltimore) 2015; 94 (43) e1814
    PubMedSuche in Google Scholar
  • 29 Leclerc F, Dubois MF, Aris A. Maternal, placental and fetal exposure to bisphenol A in women with and without preeclampsia. Hypertens Pregnancy 2014; 33 (03) 341-348
    CrossrefPubMedSuche in Google Scholar
  • 30 Asimakopoulos AG, Xue J, De Carvalho BP. , et al. Urinary biomarkers of exposure to 57 xenobiotics and its association with oxidative stress in a population in Jeddah, Saudi Arabia. Environ Res 2016; 150: 573-581
    CrossrefPubMedSuche in Google Scholar
  • 31 Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014; 64: 83-90
    CrossrefPubMedSuche in Google Scholar
  • 32 Aboul Ezz HS, Khadrawy YA, Mourad IM. The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats. Cytotechnology 2015; 67 (01) 145-155
    CrossrefPubMedSuche in Google Scholar
  • 33 Byun JA, Heo Y, Kim YO, Pyo MY. Bisphenol A-induced downregulation of murine macrophage activities in vitro and ex vivo. Environ Toxicol Pharmacol 2005; 19 (01) 19-24
    CrossrefPubMedSuche in Google Scholar
  • 34 Cindrova-Davies T. Gabor Than Award Lecture 2008: pre-eclampsia–from placental oxidative stress to maternal endothelial dysfunction. Placenta 2009; 30 (Suppl A): S55-S65
    CrossrefPubMedSuche in Google Scholar
  • 35 Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122 (04) 369-382
    CrossrefPubMedSuche in Google Scholar
  • 36 Reslan OM, Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem 2010; 8 (04) 204-226
    CrossrefPubMedSuche in Google Scholar
  • 37 Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283 (01) R29-R45
    CrossrefPubMedSuche in Google Scholar
  • 38 Bergstrom KG. Update on antibacterial soaps: the FDA takes a second look at triclosans. J Drugs Dermatol 2014; 13 (04) 501-503
    PubMedSuche in Google Scholar
  • 39 ECCC (Environment and Climate Change Canada). Canadian environmental protection act, 1999 draft federal environmental quality guidelines, triclosan. 2017. Available at: http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=F6CF7AA4-1 . Accessed July 14, 2017
    PubMed
  • 40 Cullinan MP, Palmer JE, Faddy MJ. , et al. The influence of triclosan on biomarkers of cardiovascular risk in patients in the cardiovascular and periodontal study (caps): a randomized controlled trial. J Periodontol 2015; 86 (07) 847-855
    CrossrefPubMedSuche in Google Scholar
  • 41 Shiue I. Higher urinary heavy metal, phthalate, and arsenic but not parabens concentrations in people with high blood pressure, U.S. NHANES, 2011-2012. Int J Environ Res Public Health 2014; 11 (06) 5989-5999
    CrossrefPubMedSuche in Google Scholar
  • 42 Shiue I, Hristova K. Higher urinary heavy metal, phthalate and arsenic concentrations accounted for 3–19% of the population attributable risk for high blood pressure: US NHANES, 2009-2012. Hypertens Res 2014; 37 (12) 1075-1081
    CrossrefPubMedSuche in Google Scholar
  • 43 Barros SP, Wirojchanasak S, Barrow DA, Panagakos FS, Devizio W, Offenbacher S. Triclosan inhibition of acute and chronic inflammatory gene pathways. J Clin Periodontol 2010; 37 (05) 412-418
    CrossrefPubMedSuche in Google Scholar
  • 44 Wallet MA, Calderon Nl, Alonso TR. , et al. Triclosan alters antimicrobial and inflammatory responses of epithelial cells. Oral Dis 2013; 19 (03) 296-302
    CrossrefPubMedSuche in Google Scholar
  • 45 Watkins DJ, Ferguson KK, Anzalota Del Toro LV, Alshawabkeh AN, Cordero JF, Meeker JD. Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico. Int J Hyg Environ Health 2015; 218 (02) 212-219
    CrossrefPubMedSuche in Google Scholar
  • 46 Lockwood CJ, Yen CF, Basar M. , et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008; 172 (06) 1571-1579
    CrossrefPubMedSuche in Google Scholar
  • 47 Arbuckle TE, Fraser WD, Fisher M. , et al. Cohort profile: the maternal-infant research on environmental chemicals research platform. Paediatr Perinat Epidemiol 2013; 27 (04) 415-425
    CrossrefPubMedSuche in Google Scholar
  • 48 Provencher G, Bérubé R, Dumas P. , et al. Determination of bisphenol A, triclosan and their metabolites in human urine using isotope-dilution liquid chromatography-tandem mass spectrometry. J Chromatogr A 2014; 1348: 97-104
    CrossrefPubMedSuche in Google Scholar
  • 49 Morisset AS, Weiler HA, Dubois L. , et al. Rankings of iron, vitamin D, and calcium intakes in relation to maternal characteristics of pregnant Canadian women. Appl Physiol Nutr Metab 2016; 41 (07) 749-757
    CrossrefPubMedSuche in Google Scholar
  • 50 Arbuckle TE, Marro L, Davis K. , et al. Exposure to free and conjugated forms of bisphenol A and triclosan among pregnant women in the MIREC cohort. Environ Health Perspect 2015; 123 (04) 277-284
    CrossrefPubMedSuche in Google Scholar
  • 51 Bae S, Kim JH, Lim YH, Park HY, Hong YC. Associations of bisphenol A exposure with heart rate variability and blood pressure. Hypertension 2012; 60 (03) 786-793
    CrossrefPubMedSuche in Google Scholar
  • 52 Aekplakorn W, Chailurkit LO, Ongphiphadhanakul B. Association of serum bisphenol a with hypertension in thai population. Int J Hypertens 2015; 2015: 594189
    PubMedSuche in Google Scholar
  • 53 Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health 2012; 2012: 481641
    PubMedSuche in Google Scholar
  • 54 Levin KA. Study design III: cross-sectional studies. Evid Based Dent 2006; 7 (01) 24-25
    CrossrefPubMedSuche in Google Scholar
  • 55 Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg 2010; 126 (06) 2234-2242
    CrossrefPubMedSuche in Google Scholar
  • 56 Dhingra R, Vasan RS. Age as a risk factor. Med Clin North Am 2012; 96 (01) 87-91
    CrossrefPubMedSuche in Google Scholar
  • 57 Calafat AM, Koch HM, Swan SH. , et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res 2013; 15 (05) 403
    CrossrefPubMedSuche in Google Scholar
  • 58 Lakind JS, Levesque J, Dumas P, Bryan S, Clarke J, Naiman DQ. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: bisphenol A intake as a case study. J Expo Sci Environ Epidemiol 2012; 22 (03) 219-226
    CrossrefPubMedSuche in Google Scholar
  • 59 Stacy SL, Eliot M, Etzel T. , et al. Patterns, variability, and predictors of urinary triclosan concentrations during pregnancy and childhood. Environ Sci Technol 2017; 51 (11) 6404-6413
    CrossrefPubMedSuche in Google Scholar
  • 60 Lassen TH, Frederiksen H, Kyhl HB. , et al. Prenatal triclosan exposure and anthropometric measures including anogenital distance in Danish infants. Environ Health Perspect 2016; 124 (08) 1261-1268
    CrossrefPubMedSuche in Google Scholar
  • 61 WHO (World Health Organization). Toxicological and health aspects of bisphenol A. 2010. Available at: http://apps.who.int/iris/bitstream/10665/44624/1/97892141564274_eng.pdf . Accessed January 25, 2018
    PubMed
  • 62 Queckenberg C, Meins J, Wachall B. , et al. Absorption, pharmacokinetics, and safety of triclosan after dermal administration. Antimicrob Agents Chemother 2010; 54 (01) 570-572
    CrossrefPubMedSuche in Google Scholar
  • 63 Weiss L, Arbuckle TE, Fisher M. , et al. Temporal variability and sources of triclosan exposure in pregnancy. Int J Hyg Environ Health 2015; 218 (06) 507-513
    CrossrefPubMedSuche in Google Scholar
  • 64 Bertelsen RJ, Engel SM, Jusko TA. , et al. Reliability of triclosan measures in repeated urine samples from Norwegian pregnant women. J Expo Sci Environ Epidemiol 2014; 24 (05) 517-521
    CrossrefPubMedSuche in Google Scholar
  • 65 Fisher M, Arbuckle TE, Mallick R. , et al. Bisphenol A and phthalate metabolite urinary concentrations: daily and across pregnancy variability. J Expo Sci Environ Epidemiol 2015; 25 (03) 231-239
    CrossrefPubMedSuche in Google Scholar